Foundation Consumer Healthcare owned by Kelso Private Equity and Juggernaut Capital, has entered into an agreement to acquire seven branded assets from GSK Consumer Healthcare.
The sale of the assets furthers the integration objectives between GSK and Pfizer as announced in late 2019.
Foundation has expanded its therapeutic focus with leading products that are sold globally.
Crosstree acted as exclusive financial advisor to GSK in its sale to Foundation.
This transaction further strengthens Crosstree’s extensive advisory experience with innovators in pharmaceutical products.